✦ LIBER ✦

The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer

✍ Scribed by Zhao, Jingya; Wang, Xiaoying; Xue, Liang; Xu, Nuo; Ye, Xin; Zeng, Haiying; Lu, Shaohua; Huang, Jie; Akesu, Sujie; Xu, Chen; He, Deming; Tan, Yunshan; Hong, Qunying; Wang, Qun; Zhu, Guanshan; Hou, Yingyong; Zhang, Xin

Book ID: 121544184
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 514 KB
Volume: 140
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-014-1618-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A diagnostic algorithm using EGFR mutati

A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer

✍ Kawahara, Akihiko; Taira, Tomoki; Azuma, Koichi; Tominaga, Masaki; Hattori, Sato 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 641 KB

Reaction of plasma hepatocyte growth fac

Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs

✍ Hidenori Tanaka; Tatsuo Kimura; Shinzoh Kudoh; Shigeki Mitsuoka; Tetsuya Watanab 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 242 KB

## Abstract Hepatocyte growth factor induces resistance to epidermal growth factor receptor tyrosine kinase inhibitors. It has been hypothesized that epidermal growth factor receptor tyrosine kinase inhibitors administration may influence the levels of plasma hepatocyte growth factor. Patients with

Clinical Characteristics of EGFR-TKI–Ind

Clinical Characteristics of EGFR-TKI–Induced Interstitial Pneumonitis in Korean Non–Small-Cell Lung Cancer Patients

✍ In-Jae Oh; Song Choi; Yong-Soo Kwon; Kyu-Sik Kim; Yu-Il Kim; Sung-Chul Lim; Youn 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 42 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI

✍ Yi, Hyeon Gyu; Kim, Hye Jin; Kim, Yu Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Ho 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Primary resistance to epidermal growth f

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

✍ Lee, J. K.; Shin, J.- Y.; Kim, S.; Lee, S.; Park, C.; Kim, J.- Y.; Koh, Y.; Keam 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 215 KB

KRAS mutations and resistance to EGFR-TK

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies

✍ Mao, Chen; Qiu, Li-Xin; Liao, Ru-Yan; Du, Fang-Bing; Ding, Hong; Yang, Wan-Chun; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 171 KB